Authors and Disclosures
Bernd Bokemeyer1–3, Sandra Plachta-Danielzik2, Romina di Giuseppe2, Philipp Efken4, Wolfgang Mohl5, Thomas Krause6, Martin Hoffstadt7, Robert Ehehalt8, Leo Trentmann9, Axel Schweitzer10, Petra Jessen11, Petra Hartmann4 and Stefan Schreiber2,3,*
1Interdisciplinary Crohn Colitis Centre Minden, Minden, Germany
2Competence Network IBD, Kiel, Germany
3Clinic of General Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
4Gastroenterology Practice, Minden, Germany
5Center for Gastroenterology Saar MVZ, Saarbruecken, Germany
6Gastroenterology Practice, Kassel, Germany
7Gastroenterology Practice, Iserlohn, Germany
8Gastroenterology Practice, Heidelberg, Germany
9Gastroenterology Practice, Bremen, Germany
10Gastroenterology Practice, Münster, Germany
11Group Practice at Medicum, Altenholz, Germany
Correspondence
Bernd Bokemeyer, Interdisciplinary Crohn Colitis Centre Minden, Märchenweg 17, 32439 Minden and Department of Medicine I, UKSH, Kiel University, Kiel, Germany. Email: bernd.bokemeyer@t-online.De
Bernd Bokemeyer and Sandra Plachta-Danielzik contributed equally.
*For the German Inflammatory Bowel Diseases Study Group [GISG].
Author Contributions
Bernd Bokemeyer: Conceptualization (equal); data curation (equal); funding acquisition (equal); investigation (equal); methodology (equal); project administration (equal); supervision (equal); validation (equal); writing – original draft (equal); writing – review and editing (equal). Sandra Plachta-Danielzik: Conceptualization (equal); data curation (equal); methodology (equal); project administration (equal); supervision (equal); validation (equal); writing – original draft (equal); writing – review and editing (equal). Romina di Giuseppe: Data curation (supporting); formal analysis (equal); methodology (equal); writing – original draft (supporting); writing – review and editing (supporting). Philipp Efken: Investigation (supporting); project administration (supporting); writing – review and editing (supporting). Wolfgang Mohl: Investigation (equal); project administration (supporting); writing – review and editing (supporting). Thomas Krause: Investigation (supporting); project administration (supporting); writing – review and editing (supporting). Martin Hoffstadt: Investigation (supporting); project administration (supporting); writing – review and editing (supporting). Robert Ehehalt: Investigation (supporting); project administration (supporting); writing – review and editing (supporting). Leo Trentmann: Investigation (supporting); project administration (supporting); writing – review and editing (supporting). Axel Schweitzer: Investigation (supporting); project administration (supporting); writing – review and editing (supporting). Petra Jessen: Investigation (supporting); project administration (supporting); writing – review and editing (supporting). Petra Hartmann: Conceptualization (supporting); investigation (supporting); project administration (supporting); writing – review and editing (supporting). Stefan Schreiber: Conceptualization (equal); data curation (equal); funding acquisition (equal); investigation (equal); project administration (equal); supervision (equal); writing – original draft (supporting); writing – review and editing (equal). All authors approved the final version of the manuscript.
Conflict of Interest Statement
BB has received consulting fees from: AbbVie, MSD, Shire, Ferring, Hospira, Takeda, Movetis, Shield Therapeutics, Pfizer, Biogen, Janssen, Hexal and Celgene, outside the submitted work. Financial support for lectures and teaching from: AbbVie, Ferring, MSD, Merckle, Falk, HLR, Shield Therapeutics, Pfizer, Celltrion, Takeda, Janssen and Mundipharma, outside the submitted work. Grant and financial support for research from AbbVie and Ferring, outside the submitted work. SPD have no relevant financial or non-financial interests to disclose. RdG have no relevant financial or non-financial interests to disclose. PE has received personal fees from: AbbVie, BMS, Galapagos, Janssen and Amgen, outside the submitted work. WM has received consulting fees from: AbbVie, Advanz, Amgen, Biogen, Bristol-Myers Squibb, Ferring, Fresenius Kabi, Galapagos, Hexal, Janssen and Takeda, outside the submitted work. Fees for lectures and further education from: AbbVie, alanta health service, Bristol-Myers Squibb, Galapagos, Janssen, Pfizer, Takeda and Tillotts, outside the submitted work. He is an active member of the following public law bodies: Advisory Commission of the Examination Office for the Saarland, the State Committee of Physicians and Health Insurance Companies and the Extended State Committee, and an employee in a company belonging to alanta health group GmbH, Hamburg, Germany, outside the submitted work. Shares, other fees from: AbbVie, Bayer, Gilead and GlaxoSmithKline, outside the submitted work. TK has received consulting fees from: Takeda, Janssen, Pfizer, Ferring, AbbVie and MSD, outside the submitted work. MH has received fees for studies from: Sandoz, Janssen, and AbbVie, outside the submitted work. RE has received personal fees from: Takeda, Abbvie, MSD, Biogen, Hexal, Amgen, Celltrion and Viatris, outside the submitted work. LT has no relevant financial or non-financial interests to disclose. AS has received personal fees from: AbbVie Deutschland GmbH & Co. KG, Janssen-Cilag GmbH, Tillotts Pharma, outside the submitted work. PJ has received personal fees from: AbbVie, BMS, Janssen, Falk, Medtronic, Pfizer and Ferring. PH has received consulting fees from AbbVie, Amgen, MSD, Ferring, Hospira, Takeda, Pfizer, Mylan, Biogen, Janssen, Hexal, Galapagos, BMS, and Celltrion, outside the submitted work; PH has provided speaking and teaching services for AbbVie, Amgen, Ferring, MSD, Hospira, Pfizer, Mylan, Celltrion, Takeda, Janssen and Mundipharma, outside the submitted work. SS has received personal fees from AbbVie, Arena, BMS, Biogen, Celltrion, Celgene, IMAB, Gilead, HIMA, IMAB-Biopharma, MSD, Mylan, Pfizer, Fresenius, Janssen, Takeda, Theravance, Provention Bio, Protagonist and Falk, outside the submitted work.